What happened
HEM Pharma disclosed a supply contract with HEM Pharma Japan Inc., worth US$1.4M, about 16.06% of its recent annual revenue, running through May 2027.
For context, this single contract equals about 16.06% of the company's most recent annual revenue.
| Counterparty | HEM Pharma Japan Inc. |
|---|---|
| Contract value | US$1.4M |
| vs. recent revenue | 16.06% |
| Through | May 2027 (from May 2026) |
| Filed | 2026-05-14, Supply contract signed |
| Source | DART rcept 20260514900422 → open original filing |
Source: DART. Information only, not investment advice.